ENTITY

Korea United Pharm (033270 KS)

8
Analysis
Health CareSouth Korea
Korea United Pharm., Inc. manufactures pharmaceuticals, health and beauty care products, home care goods, and special nutrition and ginseng products. The Company's products include antibiotics, vitamins and nutritional agents, and medicine for cancers.
more
01 Oct 2025 07:05

KRX Short Interest Weekly (Sep 26th): Kakao, Alteogen, Doosan Enerbility, SamsungElecMech

We analyzed KRX short interest report for the past week and highlighted short interest changes in Kakao, Alteogen, Doosan Enerbility,...

Logo
289 Views
Share
17 Sep 2025 17:37

Myungin Pharmaceutical IPO Bookbuilding Analysis

Myungin Pharm's IPO price has been confirmed at 58,000 won, which is at the high end of the IPO price range. The demand ratio was 488.9 to 1.

Logo
347 Views
Share
08 Sep 2025 10:00

Myungin Pharm Pre-IPO: Discount to Peers; Potential Succession Planning

Myungin Pharm  is looking to raise up to US$142m in its upcoming Korean IPO. In this note, we examine the IPO dynamics, and look at the firm’s...

Logo
431 Views
Share
22 Aug 2025 21:22

Myungin Pharmaceutical IPO Valuation Analysis

Our base case valuation of Myungin Pharm is target price of 80,349 won per share, which is 39% higher than the high end of the IPO price range.

Logo
1.6k Views
Share
21 Aug 2025 20:40

Myungin Pharmaceutical IPO Preview

Myungin Pharmaceutical is getting ready to complete its IPO in KOSPI in September. The IPO price range is from 45,000 won to 58,000 won.

Logo
420 Views
Share
x